We thus suggest that M10 treatment result to the prevention of the pathogenesis of chronic colitis, probable due to the regulatory effects of IL-6/NF-κB signaling pathways in the inflamed colonic epithelium. This evidence concerns the gene IL6 and Chronic colitis.